𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BIAS IN THE EVALUATION OF DNA-AMPLIFICATION TESTS FOR DETECTING CHLAMYDIA TRACHOMATIS

✍ Scribed by ALULA HADGU


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
237 KB
Volume
16
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


The purpose of this paper is to show that the sensitivity and specificity estimates obtained by 'discrepant analysis' are biased. Discrepant analysis is a widely used technique that attempts to provide estimates of sensitivity and specificity in the presence of an imperfect gold standard. Many researchers have applied this technique to estimate the sensitivity and specificity of DNA-amplification tests for Chlamydia trachomatis such as the plasmid based ligase chain reaction (LCR) and polymerase chain reaction (PCR) tests. Moreover, the June 1993 package insert of the PCR AMPLICOR Chlamydia trachomatis test contains estimates of sensitivity and specificity based on 'discrepant analysis'. Even if one employs a perfect test to resolve the discrepant results, discrepant analysis estimates of test sensitivity and specificity remain biased. Thus, one should not adopt this technique to evaluate the performance of a diagnostic test.


πŸ“œ SIMILAR VOLUMES


Letter to the editor: Bias in the evalua
✍ Julius Schachter πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 51 KB πŸ‘ 2 views

Hadgu raises concerns about how diagnostic tests for detecting Chlamydia trachomatis are evaluated and states that 'discrepant analysis strongly biases evaluations in favour of the new test'. He questions the sensitivity and specificity figures that are generated by discrepant analysis. It may be us

Analysis of the amplification refractory
✍ Low, Eva O.; Jones, Alexandra M.; Gibbins, John R.; Walker, D. Murray πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

The sensitivity of the amplification refractory mutation allele-specific polymerase chain reaction system (ARMAS-PCR) to detect known p53 mutations was determined using DNA extracted from two human tumour cell lines collected by cytobrush, as a model for its use in exfoliative cytology. Using DNA ex